Coloplast A/S (CLPBY)
6.10
+0.19
(+3.21%)
USD |
OTCM |
Jun 09, 16:00
Coloplast EPS Diluted (Quarterly) : -0.0675 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0675 |
| December 31, 2025 | 0.0966 |
| September 30, 2025 | 0.0608 |
| June 30, 2025 | 0.0543 |
| March 31, 2025 | 0.0571 |
| December 31, 2024 | 0.0663 |
| September 30, 2024 | 0.086 |
| June 30, 2024 | 0.0818 |
| March 31, 2024 | 0.0811 |
| December 31, 2023 | 0.08 |
| September 30, 2023 | 0.0798 |
| June 30, 2023 | 0.0874 |
| March 31, 2023 | 0.0784 |
| December 31, 2022 | 0.0727 |
| September 30, 2022 | 0.0784 |
| June 30, 2022 | 0.0867 |
| March 31, 2022 | 0.0694 |
| December 31, 2021 | 0.087 |
| September 30, 2021 | 0.097 |
| June 30, 2021 | 0.0953 |
| March 31, 2021 | 0.0858 |
| December 31, 2020 | 0.0854 |
| September 30, 2020 | 0.0766 |
| June 30, 2020 | 0.069 |
| March 31, 2020 | 0.0737 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0759 |
| September 30, 2019 | 0.0554 |
| June 30, 2019 | 0.0755 |
| March 31, 2019 | 0.0727 |
| December 31, 2018 | 0.0713 |
| September 30, 2018 | 0.0763 |
| June 30, 2018 | 0.0715 |
| March 31, 2018 | 0.0713 |
| December 31, 2017 | 0.0699 |
| September 30, 2017 | 0.075 |
| June 30, 2017 | 0.0635 |
| March 31, 2017 | 0.0628 |
| December 31, 2016 | 0.0646 |
| September 30, 2016 | 0.03 |
| June 30, 2016 | 0.0698 |
| March 31, 2016 | 0.0637 |
| December 31, 2015 | 0.0568 |
| September 30, 2015 | -0.1002 |
| June 30, 2015 | 0.0492 |
| March 31, 2015 | 0.0576 |
| December 31, 2014 | 0.0628 |
| September 30, 2014 | 0.07 |
| June 30, 2014 | 0.0679 |
| March 31, 2014 | -0.0017 |
| December 31, 2013 | 0.0665 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ambu A/S | 0.0711 |
| Abbott Laboratories | 0.6165 |
| AngioDynamics, Inc. | -0.1944 |
| Alphatec Holdings, Inc. | -0.2201 |
| AtriCure, Inc. | 0.0022 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -152.06M |
| Revenue (Quarterly) | 1.109B |
| Total Expenses (Quarterly) | 1.261B |
| Enterprise Value | 16.22B |
| Gross Profit Margin (Quarterly) | 42.95% |
| Profit Margin (Quarterly) | -13.71% |
| Earnings Yield | 2.36% |
| Operating Earnings Yield | 8.41% |
| Normalized Earnings Yield | 4.908 |